CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

This article is part of Life Sciences Review's Innovation Insights series featuring expert contributions nominated by our subscribers and reviewed by our editorial team.

Jack Heintzelman,  Boston Wealth Strategies | Life Science Review | Top Life Sciences Financial Services Provider

Navigating the Financial Complexity of Biotech: How Boston Wealth Strategies Empowers Innovators

Jack Heintzelman, CFP®, Partner , Boston Wealth Strategies

Biotech professionals are no strangers to complexity. From navigating FDA approvals to leading groundbreaking research, the life sciences community thrives at the intersection of science, innovation, and risk. At Boston Wealth Strategies, we bring that same spirit of precision and customization to the financial lives of biotech professionals and companies—because we understand that standard planning doesn't cut it in a nonstandard industry.

Understanding the Biotech Lifecycle

Whether you’re a scientist, executive, or founder, your financial picture is often closely tied to the unpredictable trajectory of the biotech industry. Liquidity events are concentrated and rare. Compensation structures often include incentive stock options (ISOs), non-qualified stock options (NSOs), RSUs, and milestone-based bonuses. Volatility is part of the job description—and that requires a financial partner who can bring clarity to the chaos.

Our firm supports professionals across the biotech lifecycle—from early-career researchers to late-stage founders preparing for an exit. We offer a specialized approach that integrates financial planning, investment management, and corporate retirement services to deliver a cohesive experience across personal and professional finances.

Financial Planning Rooted in Your Industry

At Boston Wealth Strategies, we take the time to understand your full financial landscape—not just your investment accounts. We look at your equity comp, deferred compensation, benefits, and long-term career goals to build a financial plan that reflects your reality.

Key areas we advise on include:

• Equity Compensation Strategies: Understanding vesting schedules, AMT exposure, 83(b) elections, and exit planning strategies for founders and employees alike.
• Cash Flow Planning: Helping clients balance high-cost-of-living expenses with long-term wealth building, especially in the high-risk/high-reward biotech environment.
• Tax Coordination: Partnering with CPAs to time stock sales, harvest losses, and navigate multi-state filings due to remote work or corporate travel.
• Estate and Legacy Planning: Aligning wealth with family priorities, philanthropic goals, and tax-efficient transfer strategies.

We don’t just create a plan—we act as your financial quarterback, coordinating across your legal, tax, and business teams to ensure every move is aligned with your long-term goals.

Investment Management Designed for Precision

Biotech professionals often have concentrated positions in company stock or limited liquidity. That’s why we offer customized investment strategies focused on:

• Tax efficiency
• Diversification of risk
• Tactical and strategic asset allocation
• Ongoing portfolio monitoring and rebalancing

Our investment process begins with discovery—understanding your goals, risk tolerance, and past experiences—then designing a strategy that evolves with you over time. We’re not here to sell a product; we’re here to steward your wealth through every phase of your journey.

  • Standard planning doesn't cut it in a nonstandard industry—biotech requires precision, flexibility, and a deep understanding of risk


Supporting Biotech Companies and Founders

Beyond individuals, we work directly with biotech companies as they scale. Our Corporate Retirement Services help founders and finance teams establish competitive, compliant 401(k) plans that attract top talent and support long-term employee financial wellness.

Our services for plan sponsors include:

• Fiduciary oversight and regulatory compliance
• Investment menu selection and plan design
• Fee and service benchmarking
• Participant education sessions tailored for biotech professionals
• Vendor management and annual plan reviews

By improving plan efficiency and employee outcomes, we help biotech companies stay competitive in an industry where human capital is everything.

Why Boston Wealth Strategies?

With over 30 years of experience, 12+ team members, and more than $1 billion in assets under advisement (as of 03/31/2025), Boston Wealth Strategies delivers the institutional knowledge and personalized service that biotech clients need. Our team includes eight CERTIFIED FINANCIAL PLANNER™ professionals who serve clients across 30+ states, with deep roots in Greater Boston—the hub of biotech innovation.

What sets us apart isn’t just our expertise, but our ability to meet you where you are. Whether you’re preparing for an IPO, navigating a layoff, or rethinking your financial strategy after a liquidity event, we’re here to guide you with clarity, empathy, and integrity.

About the Author:

Jack Heintzelman, CFP® is a Partner at Boston Wealth Strategies, where he leads the firm’s work with life sciences professionals and business owners. He is passionate about helping clients align their financial lives with their long-term impact and purpose.

Securities and advisory services offered through Commonwealth Financial Network®, Member FINRA/SIPC, a Registered Investment Advisor. Fixed insurance products and services are separate from and not offered through Commonwealth Financial Network®.

MORE FROM INNOVATION INSIGHTS

Bringing Genetic Science Into Daily Health Decisions
CRI Genetics
Alex Mulyar, Founder

Bringing Genetic Science Into Daily Health Decisions

Why to outsource disinfectant efficacy testing (DET) to a centralized laboratory
Labor LS
Anastasija Schlicht, Head of Disinfectant Efficacy Testing (DET)

Why to outsource disinfectant efficacy testing (DET) to a centralized laboratory

Navigating the Global Omega-3 Market: How to Identify a Reliable Liquid Supplement Manufacturer
Valentis
Linas Kamarauskas, Business Development Manager

Navigating the Global Omega-3 Market: How to Identify a Reliable Liquid Supplement Manufacturer

Solving Canada's Pharma Talent Gap with AI and Automation
CSols Inc
Becky Stewart, Scientific Copywriter

Solving Canada's Pharma Talent Gap with AI and Automation


EXPLORE OUR KNOWLEDGE NETWORK


View Innovation InsightsRead Leadership Perspectives

The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://life-science-financial-services.lifesciencesreview.com/innovation-insight/-cid-2240